[1] 相迪,戴建国.原发性肝癌的综合治疗研究进展.山东医药,2017,57:111-113.
[2] Gli-1与EMT相关蛋白在非小细胞肺癌中的表达及临床意义. 中国肿瘤临床, 2017,54:1232-1237.
[3] 黄涛, 梁荣班, 陈娟,等. 原发性肝癌组织中Ezrin蛋白表达的临床意义及其与预后相关性研究. 中国临床药理学杂志, 2016, 32:1400-1402.
[4] 中国抗癌协会肝癌专业委员会. 原发性肝癌规范化病理诊断指南(2015年版). 中华肝胆外科杂志, 2015, 21:833-839.
[5] Snail与Claudin-3蛋白的表达与原发性肝癌发生及预后的关联性研究. 首都医科大学学报, 2018, 39:393-397.
[6] Li X, Chen H, Liu Z,et al. Overexpression of MIST1 reverses the epithelial-mesenchymal transition and reduces the tumorigenicity of pancreatic cancer cells via the Snail/E-cadherin pathway. Cancer Lett, 2018,431:96-104.
[7] Mathieu E, Meheus L, Raymackers J, et al. Characterization of the osteogenic stromal cell line MN7: identification of secreted MN7 proteins using two-dimensional polyacrylamide gel electrophoresis, western blotting, and microsequencing. J Bone Miner Res, 1994,9:903-13.
[8] 许淼, 秦成勇, 刘瑛. HS-1200对二乙基亚硝胺诱导原发性肝癌大鼠肝脏的保护作用及机制. 山东医药, 2017, 57:34-36. |
